Statera BioPharma (STAB) Stock Statistics & Valuation Metrics

Statera BioPharma has a market cap or net worth of $7.14K. The enterprise value is $14.42M.

Statera BioPharma has 71,416,040 shares outstanding. The number of shares has decreased by -2.65% in one year.

Statera BioPharma’s return on equity (ROE) is 111.23 and return on invested capital (ROIC) is -666.54%.

The current PE Ratio of Statera BioPharma is ―. Statera BioPharma’s PEG ratio is -0.00054.

In the last 12 months, Statera BioPharma had revenue of 0.00 and earned -174.41M in profits. Earnings per share was -4.97.

In the last 12 months, operating cash flow was -12.86M and capital expenditures -103.37K, giving a free cash flow of -12.96M billion.

Statera BioPharma pays an annual dividend of ―, resulting in a dividend yield of ―

Statera BioPharma upcoming earnings date is ―, ―.

Statera BioPharma as a current ratio of 0.37, with Debt / Equity ratio of -1037.04%

In the past 12 months, Statera BioPharma has paid 72.53M in taxes.

Statera BioPharma EV to EBITDA ratio is -0.56, with an EV/FCF ratio of -3.35.

Statera BioPharma has $506.10K in cash and marketable securities with $7.41M in debt, giving a net cash position of -$6.90M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Statera BioPharma is ―, which is 11.43% higher than the current price. The consensus rating is ―